We recently published 10 Stocks Jim Cramer Talked About. Medline Inc. (NASDAQ:MDLN) is one of the stocks Jim Cramer discussed recently. Medical supplies and instrument firm Medline Inc.

If you are wondering whether Medline is quietly undervalued or just fairly priced at current levels, you are not alone. This article unpacks what the market might be missing. So far this year, Medline ...

The banner across Medline's homepage today reads, "We're public." It's a bit of an understatement. The Northfield-based global medical supplies company on Dec. 16 offered about 216 million shares at ...

Medline Inc. (NASDAQ:MDLN) is one of the stocks Jim Cramer shed light on. Cramer discussed the company’s IPO during the episode, as he remarked: “So is Medline worth buying after today’s IPO and the ...

The latest update is out from Medline, Inc. Class A ( (MDLN)). On December 16, 2025, Medline Inc. put in place a suite of governance and investor-rights agreements tied to its initial public offering, ...

The owners of Medline Industries Inc., one of the largest medical equipment companies, have attracted Goldman Sachs Group Inc. and Morgan Stanley to conduct an IPO in the United States. This is ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

What did Micron’s earnings tell us about the AI boom? And what’s behind the corporate dramas at Warner Bros. Discovery and Lululemon? Plus, does Medline's IPO splash bode well for future offerings?

Visceral leishmaniasis (VL) is a severe infectious disease caused by a protozoan parasite: Leishmania donovani in East Africa and the Indian subcontinent and Leishmania infantum in Latin America and ...